References
- Baker PJ. Developing a blueprint for evidence-based drug prevention in England. Drugs: Education, Prevention and Policy 2006; 13(1)17–32
- Faggiano F, Vigna-Taglianti FD, Versino E, Zambon A, Borraccino A, Lemma P. School-based prevention for illicit drugs’ use. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD003020. (DOI: 10.1002/14651858.CD003020.pub2)
- Ferri M, Davoli M, Perucci CA. Heroin maintenance for chronic heroin dependents. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD003410. (DOI: 10.1002/14651858.CD003410.pub2)
- Haasen C, Verthein U, Degkwitz P, Berger J, Krausz M, Naber D. Heroin-assisted treatment for opioid dependence: Randomised controlled trial. British Journal of Psychiatry 2007; 191: 55–62
- Jones L, Sumnall H, Burrell K, McVeigh J, Bellis MA. Universal drug prevention. National Collaborating Centre for Drug Prevention, Liverpool, UK 2006
- March JC, Oviedo-Joekes E, Perea-Milla E, Carrasco F. Controlled trial of prescribed heroin in the treatment of opioid addiction. Journal of Substance Abuse Treatment 2006; 31(2)203–211,
- NICE. Methadone and buprenorphine for the management of opioid dependence (NICE technology appraisal 114). National Institute for Health and Clinical Excellence, London 2007a
- NICE. Opiate detoxification for drug misuse (NICE clinical guideline 52). National Institute for Health and Clinical Excellence, London 2007b
- NICE. Psychosocial management of drug misuse (NICE Clinical Guideline 51). National Institute for Health and Clinical Excellence, London 2007c
- Reuter P, Stevens A. An analysis of UK drug policy. UK Drug Policy Commission, London 2007